Sunday 27 May 2018
Contact US    |    Archive
Reuters
3 months ago

Germany s CureVac wins new vaccine funding from Gates Foundation

Feb 13 (Reuters) - German biotech firm CureVac has secured more financial backing for vaccine development projects from its investor the Bill and Melinda Gates Foundation, working on jabs to prevent malaria and influenza.

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.
Hashtags:   

Germany

 | 

CureVac

 | 

wins

 | 

new

 | 

vaccine

 | 

funding

 | 

from

 | 

Gates

 | 

Foundation

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
USA